63 related articles for article (PubMed ID: 16004557)
1. Rapid genotyping of the OATP1B1 polymorphisms A388G and T521C with real-time PCR FRET assays.
Op den Buijsch RA; Wijnen PA; van Dieijen-Visser MP; de Vries JE; Bekers O
Pharmacogenomics; 2005 Jun; 6(4):393-7. PubMed ID: 16004557
[TBL] [Abstract][Full Text] [Related]
2. [OATP 1B1 T521C/A388G is an important polymorphism gene related to neonatal hyperbilirubinemia].
Zhang HX; Zhao X; Yang Z; Peng CY; Long R; Li GN; Li J; He ZK
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):650-5. PubMed ID: 21092521
[TBL] [Abstract][Full Text] [Related]
3. Association of CYP2D6*10, OATP1B1 A388G, and OATP1B1 T521C polymorphisms and overall survival of breast cancer patients after tamoxifen therapy.
Zhang X; Pu Z; Ge J; Shen J; Yuan X; Xie H
Med Sci Monit; 2015 Feb; 21():563-9. PubMed ID: 25701109
[TBL] [Abstract][Full Text] [Related]
4. Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing.
Rohrbacher M; Kirchhof A; Skarke C; Geisslinger G; Lötsch J
Pharmacogenomics; 2006 Mar; 7(2):167-76. PubMed ID: 16515396
[TBL] [Abstract][Full Text] [Related]
5. Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics.
Katz DA; Carr R; Grimm DR; Xiong H; Holley-Shanks R; Mueller T; Leake B; Wang Q; Han L; Wang PG; Edeki T; Sahelijo L; Doan T; Allen A; Spear BB; Kim RB
Clin Pharmacol Ther; 2006 Mar; 79(3):186-96. PubMed ID: 16513443
[TBL] [Abstract][Full Text] [Related]
6. Organic anion transporter protein (OATP1B1) encoded by SLCO1B1 gene polymorphism (388A>G) & susceptibility in gallstone disease.
Jindal C; Kumar S; Choudhari G; Goel H; Mittal B
Indian J Med Res; 2009 Feb; 129(2):170-5. PubMed ID: 19293444
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of gene polymorphisms involved in bilirubin production and metabolism.
Lin Z; Fontaine J; Watchko JF
Pediatrics; 2008 Jul; 122(1):e156-62. PubMed ID: 18558634
[TBL] [Abstract][Full Text] [Related]
8. Rapid detection of the R389G polymorphism of ADRB1 by real time PCR using fluorescence resonance energy transfer.
Sauer M; Tews J; Schwarzer M; Seeburger J; Adams V; Falk V; Dhein S; Mohr FW
Clin Lab; 2009; 55(3-4):128-36. PubMed ID: 19462935
[TBL] [Abstract][Full Text] [Related]
9. Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.
Oswald S; König J; Lütjohann D; Giessmann T; Kroemer HK; Rimmbach C; Rosskopf D; Fromm MF; Siegmund W
Pharmacogenet Genomics; 2008 Jul; 18(7):559-68. PubMed ID: 18551036
[TBL] [Abstract][Full Text] [Related]
10. Rapid detection of the factor XIII Val34Leu (163 G-->T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis.
Shemirani AH; Muszbek L
Clin Chem Lab Med; 2004; 42(8):877-9. PubMed ID: 15387436
[TBL] [Abstract][Full Text] [Related]
11. The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamics.
Vormfelde SV; Toliat MR; Schirmer M; Meineke I; Nürnberg P; Brockmöller J
Clin Pharmacol Ther; 2008 Jun; 83(6):815-7. PubMed ID: 18043684
[No Abstract] [Full Text] [Related]
12. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
Pasanen MK; Neuvonen M; Neuvonen PJ; Niemi M
Pharmacogenet Genomics; 2006 Dec; 16(12):873-9. PubMed ID: 17108811
[TBL] [Abstract][Full Text] [Related]
13. Direct and rapid genotyping of SLCO1B1 388A>G and 521T>C in human blood specimens using the SmartAmp-2 method.
Yoshida K; Takano J; Ishizu Y; Lezhava A; Ieiri I; Maeda K; Hayashizaki Y; Sugiyama Y
AAPS J; 2013 Apr; 15(2):618-22. PubMed ID: 23471819
[TBL] [Abstract][Full Text] [Related]
14. Global analysis of genetic variation in SLCO1B1.
Pasanen MK; Neuvonen PJ; Niemi M
Pharmacogenomics; 2008 Jan; 9(1):19-33. PubMed ID: 18154446
[TBL] [Abstract][Full Text] [Related]
15. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport.
Mahagita C; Grassl SM; Piyachaturawat P; Ballatori N
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G271-8. PubMed ID: 17412826
[TBL] [Abstract][Full Text] [Related]
16. An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure.
Vandell AG; Lee J; Shi M; Rubets I; Brown KS; Walker JR
Pharmacogenomics J; 2018 Jan; 18(1):153-159. PubMed ID: 27897269
[TBL] [Abstract][Full Text] [Related]
17. No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone.
Kalliokoski A; Neuvonen M; Neuvonen PJ; Niemi M
Br J Clin Pharmacol; 2008 Jan; 65(1):78-86. PubMed ID: 17635496
[TBL] [Abstract][Full Text] [Related]
18. Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1).
Niemi M; Kivistö KT; Hofmann U; Schwab M; Eichelbaum M; Fromm MF
Br J Clin Pharmacol; 2005 May; 59(5):602-4. PubMed ID: 15842561
[No Abstract] [Full Text] [Related]
19. OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation.
Zhang W; He YJ; Gan Z; Fan L; Li Q; Wang A; Liu ZQ; Deng S; Huang YF; Xu LY; Zhou HH
Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1240-4. PubMed ID: 17973861
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte nuclear factor 1 alpha is a factor responsible for the interindividual variation of OATP1B1 mRNA levels in adult Japanese livers.
Furihata T; Satoh T; Yamamoto N; Kobayashi K; Chiba K
Pharm Res; 2007 Dec; 24(12):2327-32. PubMed ID: 17932728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
